Bipolar Disorder Clinical Trial
Official title:
An Open Label, Naturalistic Study With Allopurinol Augmentation for Prevention of Mania in Bipolar Disorder
The purpose of this study is to investigate the efficacy of allopurinol as an augmentation agent for the prevention of mania in bipolar disorder patients with currently stable mood.
The purpose of this study is to investigate the efficacy of allopurinol as an augmentation
agent for the prevention of mania in bipolar disorder patients with currently stable mood.
Bipolar disorder is a mental disorder with severe mood swings (mania and depression). Despite
the development of medications for mania, they may have significant side effects, high costs
and the need for serum level monitoring. These factors adversely affect medication compliance
in bipolar patients. One recent study indicated the efficacy of allopurinol in the treatment
of bipolar mania. Our hypothesis is that the addition of allopurinol to standard medications
for bipolar disorder will decrease the recurrences of manic episodes compared to standard
medications.
This study will recruit bipolar disorder patients currently mood stable on a therapeutic dose
of an anti-manic medication. Stable mood will be defined as a Young Mania Rating Scale score
≤10 and Hamilton Depression Rating Scale ≤10. Subjects must have a diagnosis of bipolar
disorder confirmed by the Mini International Neuropsychiatric Interview. Young Mania Rating
Scale and Mini International Neuropsychiatric Interview are common research questionnaires
used in bipolar disorder studies. Potential subjects will be identified and approached during
an outpatient clinical visit by a member of the research team and identified by their
treating physicians and referred to the researchers.
This study involves adding allopurinol to subjects' current bipolar medications. This study
will be a open label, naturalistic study. The subject will be examined monthly for manic
symptoms for 2 years. Semi-structured interviews and study questionnaires will be
administered to subjects at each visit. Monthly Follow-up Study Visits (once per month for 2
years - Months 1-5, 7-11, 13-17, 19-23) may be conducted either in-person or over the phone.
All of the questionnaires will be administered by a clinician if the visit is completed over
the phone. However, the 6-month interval visits (Months 6, 12, 18, and 24) must be done at
the research center.
The primary outcome measure will be the number of manic episodes in the 2 year study period.
A manic episode will be defined by a Young Mania Rating Scale score ≥20.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT02855762 -
Targeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
|
N/A | |
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Recruiting |
NCT05206747 -
Ottawa Sunglasses at Night for Mania Study
|
N/A | |
Completed |
NCT02513654 -
Pharmacokinetics, Safety and Tolerability of Repeat Dosing Lamotrigine in Healthy Chinese Subjects
|
Phase 1 | |
Recruiting |
NCT06313918 -
Exercise Therapy in Mental Disorders-study
|
N/A | |
Completed |
NCT02304432 -
Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine
|
Early Phase 1 | |
Recruiting |
NCT06197048 -
Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03497663 -
VIA Family - Family Based Early Intervention Versus Treatment as Usual
|
N/A | |
Completed |
NCT04284813 -
Families With Substance Use and Psychosis: A Pilot Study
|
N/A | |
Completed |
NCT02212041 -
Electronic Cigarettes in Smokers With Mental Illness
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Recruiting |
NCT04298450 -
ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention
|
N/A | |
Active, not recruiting |
NCT03641300 -
Efficacy of Convulsive Therapies for Bipolar Depression
|
N/A | |
Not yet recruiting |
NCT04432116 -
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
|
N/A | |
Completed |
NCT02970721 -
Use of Psychotropic Medications Among Pregnant Women With Bipolar Disorder
|
||
Terminated |
NCT02909504 -
Gao NARASD Lithium Study
|
Phase 4 | |
Terminated |
NCT02893371 -
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
|
||
Recruiting |
NCT03088657 -
Design and Methods of the Mood Disorder Cohort Research Consortium (MDCRC) Study
|
||
Recruiting |
NCT02481245 -
BezafibrateTreatment for Bipolar Depression: A Proof of Concept Study
|
Phase 2 |